Master the R Series Bootcamp - February 6, 13, 20, and 27. Registration is now open.
Register Now
NIH Expertise

1:1 for R or K

Our goal with an applicant is not to improve a single submission but to improve our client’s skills as an applicant, reviewer, and mentor on all grant submissions going forward. 

NIH Grantwriting Program

We work with universities and academic medical centers to mentor faculty in NIH grantwriting in the R and K Series.

The NIH Grantwriting Program is a comprehensive, multi-modal approach to give applicants the best chance of landing an NIH R or K grant.

This approach includes:

  • 1:1 mentoring, emphasizing preparatory steps before writing
  • Line-by-line editing of Specific Aims page, Research Strategy, and Biosketch; if applicable, Introduction, Candidate Section
  • A full year of access to select virtual grantwriting courses, packed with templates and samples from recent successful applications
  • Step-by-step instructions and checklists, with progress tracked in a learning management system 
  • Reminders and interim deadlines to help pace applicants to deadline
  • Access to every-other-week Live Member Q & A with Dr. Bouvier and colleagues
  • After the review, a discussion of Summary Statements and next steps
Hispanic girl with down syndrome working at scientist laboratory smiling showing both hands open palms, presenting and advertising comparison and balance.

Contracting:

We contract with universities and academic medical centers on behalf of groups of R/K applicants.

We do not contract with individuals nor for individual R or K submissions. For details on contracting with our company

Contact Us for Contracting Enquiries

NIH Grant Mechanisms

These are mechanisms on which Dr. Bouvier has direct experience:

  • R01 Research Project Grant
  • R01 Katz ESI Award
  • BRP R01 Bioengineering Research Partnerships 
  • R01 Outstanding New Environmental Scientist (ONES) Award
  • R01 Partnerships for Biodefense
  • R03 Small Grant Program
  • R13 Support for Conferences and Scientific Meetings
  • R15 Academic Research Enhancement Award (AREA)
  • R18 Research Demonstration & Dissemination Projects
  • R21 Exploratory/Developmental Research Grant Award
  • R21/R33 Phased Innovation Award
  • R25 Support for Short Courses
  • R34 Clinical Trial Planning Grant
  • R35 Outstanding Investigator Award
  • R35 Maximizing Investigators’ Research Award (MIRA)
  • R37 NCI MERIT (conversion from R01)
  • R61/R33-RISK Research Innovations for Scientific Knowledge (RISK)
  • RC1 Challenge Grants
  • RC2 High Impact, Interdisciplinary Science in NIDDK Research Areas
  • RC4 Recovery Act Grants
  • K01 Mentored Research Scientist Development Award
  • K01 International Research Scientist Development Award (IRSDA)
  • K08 Mentored Clinical Scientist Research Career Development Award
  • K22 Career Transition Award
  • K23 Mentored Patient-Oriented Research Career Development Award
  • K99/R00 NIH Pathway to Independence Award
  • DP1 NIH Director’s Pioneer Award
  • DP2 NIH Director’s Innovator Award
  • TR01 NIH Director’s Transformative Research Award
  • DP5 NIH Director’s Early Independence Award
  •  
  • DP3 Diabetes Impact Award
  • Loan Repayment Programs
  • Minority Supplements
  • Administrative Supplements
  • Sources Sought
  • Contract Proposals
  • F31/F32
  •  

What our clients have to say

“I think the work you did to help me frame the question was extremely effective — it is the first time that the [reviewers’] comments have felt entirely about the science and I haven’t read it and said to myself “but I did say that” or “but I am doing that”.
Dr. Kate WolinSurgery Faculty, Washington University School of Medicine
“Meg was instrumental for me in obtaining funding. When I started the process, I knew nothing about NIH funding, and she took the time to guide me through the process and answer my questions. I attended her seminar on grant writing, and her critical reviews of my grant were excellent and allowed me to understand how to get my thoughts/ideas across in a coherent, meaningful way. Thank you Meg!!!!”
Andrea V. Barrio MD FACSSurgeon
Top 3 Cancer Hospital
“I would highly recommend this program to anyone applying for grants. I would not hesitate to continue working with Dr. Bouvier on every NIH submission.”
Jonathan Boyce PhDAssistant Professor of Medicinal Chemistry and Pharmacognosy
Top 5 Largest Cancer Hospital
“Meg has provided expert editing/writing services assisting me with several NIH grant applications. She has an extraordinary ability to take my technical content and make it ‘sellable’ to grant reviewers. She has worked with me on 3 grant proposals. All three were funded!”
Dr. Patty FreedsonChair Department of Kinesiology, University of Massachusetts
“Meg – your edits are fabulous. I can’t thank you enough for fitting my faculty member into your busy, busy schedule. Thanks so much again.”
Dr. Barbara AinsworthAssociate Director Health Promotion Faculties, Arizona State University
“I get a kick out of how you phrase your written feedback on my NIH submission. I feel like we are actually having a conversation, which I really like.”
Dr. Cirleen DeBlaereCounseling and Psychology Program Faculty, Georgia State University
“Meg exemplifies talent, hard work and meticulousness through her grantsmanship and critical thinking skills as a successful bench scientist. Meg consistently goes above the proverbial “call of duty” to see a project through to the very end, no matter what. I have learned a lot from Meg and consider myself fortunate to have had the opportunity to work with her.”
JoAnne GoodnightFormer Program Coordinator of the entire NIH SBIR/STTR Program; Currently Director of Project Development and Analysis, The Jackson Laboratory
“I had a funny exchange with my colleague who looked at my grant and said you’re writing has gotten so much better! I asked her what she meant and she pointed to all the things you edited. I had to laugh. But thought I’d pass on the compliment. And thank you again for your edits.”
Anonymous PhDAttending
“The first grant we worked together on did really well! They actually specifically complimented the packaging and presentation. We went below the funding line on our first try (even without the ESI bonus), which means the R01 will be converted to an R37 award (2 extra years of funding). So it really could not have gone better.”
Anonymous MD, PhDR37 (MIRA) recipient, Cancer Biology & Genetics, Top-Tier Medical Center
“I wanted to give you an update on the R01 that you helped me write. I got the grant on the first submission. Thank you so much for making it a great grant! You are worth every penny. I hope to work with you again in the future.”
Marc K. Halushka MD, PhD Professor, Department of Pathology
“Thank you so much for your kind words about my application as well as the thoughtful and thorough review. I particularly appreciate the rationale provided that I can apply in applications moving forward.”
Kelsey S. Dickson PhDAssociate Professor
Child and Family Development
San Diego State University
"I cannot express my gratitude for the help you provided. This was an incredible experience for me and I will recommend it to everyone I know!"
Dr. Dario PalmieriNCI-designated Comprehensive Cancer Center
"Dr. Bouvier's videos are essential to understanding how to best structure your Aims, Significance, Innovation, and Approach sections. She helps to make a set of overwhelming R01 instructions more transparent and feasible... She is an expert wordsmith as well as a great support to first time female grant writers. "
Dr. Sharla Wells-Di GregorioNCI-Designated Comprehensive Cancer Center
Previous
Next

How Can We Help?

Let’s have a conversation about how we can help your faculty improve their NIH grantsmanship skills.
Contact Us
Bouvier Grant Group logo white

Wait!

Subscribe to our monthly newsletter for the latest NIH news, grantwriting tips, and more.

NIH October 2023 Newsletter cover
  • We value your privacy and will never sell your information.